Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
ILS 52.78
ILS 4750.47ILS 52.78
ILS 633.07
60 tablet
Free AirMail shipping Hot
ILS 56.30
ILS 3378.06ILS 56.30
ILS 210.96
30 tablet
Free AirMail shipping Hot
ILS 59.82
ILS 1794.51ILS 59.82
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
ILS 63.34
ILS 5700.60ILS 63.34
ILS 316.36
60 tablet
Free AirMail shipping Hot
ILS 65.10
ILS 3905.91ILS 65.10
ILS 105.39
30 tablet
Free AirMail shipping Hot
ILS 66.86
ILS 2005.65ILS 66.86
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
ILS 75.66
ILS 6809.09ILS 75.66
ILS 316.36
60 tablet
Free AirMail shipping Hot
ILS 77.42
ILS 4644.90ILS 77.42
ILS 105.39
30 tablet
Free AirMail shipping Hot
ILS 79.17
ILS 2375.15ILS 79.17
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.